Dishman Pharma Sept qtr net sales are anticipated to increase by 9percent

KR Choksey released its earning estimations on Pharma_sector for the qtr closed Sept 2011. Based on the research company, Dishman Pharma Sept qtr net sales are anticipated to increase by 9percent at Rs 254 cr, yoy, (Year-on-year) time frame.

The firm’s net gain is anticipated to decrease 50percent at Rs 15 cr cr on Year-on-year basis

Be Sociable, Share!
Tags:

Stock Market Basics For Beginners

Why Do Companies Split Their Stock? Stock Split Good?

Why Do Companies Split Their Stock? Stock Split Good? [ad name="468x15- 5 link"] A company splits their stock because administration has a theoretical ideal price range for the firm’s stock. If the market price of ...…

Common shares

Common shares Common shares are standard shares with no particular restrictions or rights and have the potential to provide the highest financial gain, but ordinary shares (common ...…

What is Listing of Securities?

What is Listing of Securities? Means for Listing;- Admission of securities of the issuer to buying and selling rights (dealings) on a stock exchange by way of a formal agreement. ...…

Bombay Stock Exchange Of India (BSE)

Bombay Stock Exchange Of India (BSE) Bombay Exchange Sensitive Index ( SENSEX) - the benchmark index of the Bombay Stock Exchange (BSE)  also called the "BSE 30", is a widely used ...…

SEBI’s Role in an IPO Issue

SEBI’s Role in an IPO Issue Any firm doing a public issue or a listed firm building a rights issue of value of greater than Rs 50 lakh is needed to ...…

Indian Share Tips

NSE Investment Site

Market Update

Share Guide

Designed by VMV
web
analytics